Novo Nordisk A/S reported DKK1.4T in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Bausch Health Companies USD 2.18B 430.06M Sep/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Eli Lilly USD 1.09T 40.33B Sep/2026
GlaxoSmithKline GBP 74.11B 6.03B Sep/2026
Merck USD 358.5B 41.13B Sep/2026
Novo Nordisk DKK 212.17B 55.02B Jun/2026
Novo Nordisk A/S DKK 1.4T 373.76B Jun/2026
Pacira USD 998M 83M Jun/2026
Supernus Pharmaceuticals USD 2.51B 193M Sep/2026